Search Browse Earnings

CalciMedica, Inc. — SlamSEC

CalciMedica, Inc.

Nasdaq:CALC

Pharmaceutical Preparations·LA JOLLA, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$24.2M

FY 2025

Net Income

-$13.7M

FY 2025

EPS (Diluted)

-$1.22

FY 2025

Stock Price

$0.73

+0.9%

2026-03-09

52W Range

$0.46 – $7.20

P/E Ratio

-0.6x

Market Cap

$11.6M

Cash

$7.9M

FY 2025

Total Debt

—

Net Cash

$7.9M

Enterprise Value

$3.6M

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-0.1x

Employees

—